Sign In / Join

favorite Donate

close

person Sign In / Create Account

HealthTree News

HealthTree News is a place to learn all about your disease in easy-to-understand language. The site features news articles, patient stories, basics articles, and clinical trial updates with new content every week.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Updates in Treatment Options for TP53-Mutant AML and MDS

Dec. 19, 2024

Updates in Treatment Options for TP53-Mutant AML and MDS

Former NHL Player Kelly Chase Shares an Update on His AML Treatment

Dec. 17, 2024

Former NHL Player Kelly Chase Shares an Update on His AML Treatment

U.S. Study Shows Social and Economic Factors Limit Access to AML Transplants

Dec. 13, 2024

U.S. Study Shows Social and Economic Factors Limit Access to AML Transplants

The Best of ASH 2024

Dec. 10, 2024

The Best of ASH 2024

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

Dec. 10, 2024

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

Busy Day ASH 2024: AML Research in the Spotlight

Dec. 08, 2024

Busy Day ASH 2024: AML Research in the Spotlight

First Day of ASH 2024- Busy Times in Leukemia Research!

Dec. 06, 2024

First Day of ASH 2024- Busy Times in Leukemia Research!

What is the ASH Conference?

Dec. 02, 2024

What is the ASH Conference?

Possible Drug Coverage Changes in 2025 for Medicare and Other Insurance Plans

Dec. 02, 2024

Possible Drug Coverage Changes in 2025 for Medicare and Other Insurance Plans

Eight Tips to Reduce Caregiver Burnout

Nov. 22, 2024

Eight Tips to Reduce Caregiver Burnout

The Basics of Estate and Legacy Planning

Nov. 21, 2024

The Basics of Estate and Legacy Planning

FDA Approves New Treatment for R/R Acute Leukemia with KMT2A Translocation: Revumenib

Nov. 19, 2024

FDA Approves New Treatment for R/R Acute Leukemia with KMT2A Translocation: Revumenib

Recent Articles

How to Truly Help Blood Cancer Caregivers and What to Possibly Avoid image

How to Truly Help Blood Cancer Caregivers and What to Possibly Avoid

November 18, 2024

Blood cancer caregivers shared community support tips. Learn how you can help and what to reconsider before acting.

Managing the Caregiver Roles: Chef, Chauffeur, Secretary, and More image

Managing the Caregiver Roles: Chef, Chauffeur, Secretary, and More

November 15, 2024

Learn insights about how to manage the many different responsibilities that come with a blood cancer caregiver role.

Flu and Covid-19 Vaccines: Should You Bundle Your Shots This Season? image

Flu and Covid-19 Vaccines: Should You Bundle Your Shots This Season?

November 06, 2024

Learn recent research divulging if it's wise for blood cancer patients to bundle their flu and COVID-19 vaccinations this winter season.

Treatment Advances

Updates in Treatment Options for TP53-Mutant AML and MDS image

Updates in Treatment Options for TP53-Mutant AML and MDS

FDA Approves New Treatment for R/R Acute Leukemia with KMT2A Translocation: Revumenib image

FDA Approves New Treatment for R/R Acute Leukemia with KMT2A Translocation: Revumenib

AML: Donor Age, Not Just a Number image

AML: Donor Age, Not Just a Number

Venetoclax + Decitabine Improve Senior AML Patients’ Chances of Receiving a Transplant image

Venetoclax + Decitabine Improve Senior AML Patients’ Chances of Receiving a Transplant

NPM1 Mutation in AML: Prognosis, Testing, & Treatments image

NPM1 Mutation in AML: Prognosis, Testing, & Treatments

New Trial Required for Iomab-B FDA Approval image

New Trial Required for Iomab-B FDA Approval

Load More

Core Education

What are FLT3 Inhibitors, and How are They Used in AML? image

What are FLT3 Inhibitors, and How are They Used in AML?

What is Pancytopenia? Symptoms, Causes, & Treatments image

What is Pancytopenia? Symptoms, Causes, & Treatments

What Are The AML Types, and How Are They Classified? image

What Are The AML Types, and How Are They Classified?

Does AML Go to the Brain? image

Does AML Go to the Brain?

What is Relapsed & Refractory AML? image

What is Relapsed & Refractory AML?

What Is The Difference Between Chronic And Acute Leukemia? image

What Is The Difference Between Chronic And Acute Leukemia?

Load More

Trending Articles

AML: Donor Age, Not Just a Number

Busy Day ASH 2024: AML Research in the Spotlight

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

NPM1 Mutation in AML: Prognosis, Testing, & Treatments

Former NHL Player Kelly Chase Shares an Update on His AML Treatment

Patient Stories

articles for Patient Stories

Former NHL Player Kelly Chase Shares an Update on His AML Treatment James' Journey with AML: A Story of Resilience and Acceptance Meet AML Coach, Steve Hodges

HealthTree Research

articles for HealthTree Research

Revolutionizing Blood Cancer Care: HealthTree Foundation's Commitment to Innovation Share HealthTree Cure Hub to Accelerate AML Research Participate in AML Research: Transportation Survey

Conferences

articles for Conferences

U.S. Study Shows Social and Economic Factors Limit Access to AML Transplants The Best of ASH 2024 Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

Clinical Trials

articles for Clinical Trials

Recruiting Trials for New Therapy Regimen for AML Patients RVU120: A New Treatment in Clinical Trials for AML, MDS, and Myelofibrosis CAR-T Therapy Trial for Relapsed/Refractory Acute Myeloid Leukemia

HealthTree Press

articles for HealthTree Press

HealthTree Foundation Featured on Fox News HealthTree Foundation Featured on ABC News HealthTree Foundation Announces Launch of HealthTree Research Hub in Multiple Myeloma

HealthTree Programs

articles for HealthTree Programs

The Future of Blood Cancer: Advances in Detection, Treatment, and Research AML and Fertility: Unlocking Knowledge with HealthTree University for AML How Can Patient Navigators Help Me Access Cancer Care?

Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:

Abbvie

Astellas Pharma

Servier

Follow Us

Charity Navigator

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2024 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811